Home » Sinovac Biotech Gains on Clinical Trials for Flu Vaccines
Sinovac Biotech Gains on Clinical Trials for Flu Vaccines
Shares of Sinovac Biotech Ltd. are gaining ground in premarket trading after the China-based biopharmaceutical company said that it received approval from the China State Food and Drug Administration to move forward on trials for its pandemic influenza vaccines.
Small Cap Investor
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May